Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
Abstract Glioblastomas (GBMs) are the most common and aggressive malignant brain tumors, presenting significant challenges for treatment due to their invasive nature and localization in critical brain regions. Standard treatment includes surgical resection followed by radiation and adjuvant chemothe...
| Published in: | Journal of Nanobiotechnology |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-024-02882-x |
